Pharmacists see Wal-Mart $4 generics as PR ploy
More than half of the respondents to a Drug Topics on-line survey believe that the move by Wal-Mart to offer some generic drugs for $4 is designed to attract more foot traffic to the retail giant's stores. Nearly 1,200 people responded to the survey, which was posted on the Drug Topics Web site during October. Another 24% of the respondents felt that the move would draw customers away from other pharmacies that cannot meet the Wal-Mart price, although only 10% of respondents believe that the move would sharpen competition and perhaps lead to a price war. A slightly larger number12%responded that the move will not influence patients to switch pharmacies, and 2% did not know what the impact would be.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
